2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary

TF Chao, B Joung, Y Takahashi, TW Lim… - Thrombosis and …, 2022 - thieme-connect.com
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …

Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies

A Tzikas, DR Holmes Jr, S Gafoor, CE Ruiz… - Ep …, 2017 - academic.oup.com
The increasing interest in left atrial appendage occlusion (LAAO) for ischaemic stroke
prevention in atrial fibrillation (AF) fuels the need for more clinical data on the safety and …

Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report

GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo… - Chest, 2018 - Elsevier
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion–an update

M Glikson, R Wolff, G Hindricks, J Mandrola… - EP …, 2020 - academic.oup.com
This article has been co-published with permission in EP Europace and EuroIntervention. All
rights reserved. VC 2019 the European Heart Rhythm Association and the European …

2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation …

Authors/Task Force Members, AJ Camm… - European heart …, 2012 - academic.oup.com
ESC Guidelines 2721 the outcome of disease may be favourably influenced by the thorough
application of clinical recommendations. Thus, the task of writing guidelines covers not only …

Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial

VY Reddy, H Sievert, J Halperin, SK Doshi… - Jama, 2014 - jamanetwork.com
Importance While effective in preventing stroke in patients with atrial fibrillation (AF), warfarin
is limited by a narrow therapeutic profile, a need for lifelong coagulation monitoring, and …

[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With …

VY Reddy, S Möbius-Winkler, MA Miller… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this study was to assess the safety and efficacy of left atrial
appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin …

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial …

VY Reddy, SK Doshi, H Sievert, M Buchbinder… - Circulation, 2013 - Am Heart Assoc
Background—The multicenter PROTECT AF study (Watchman Left Atrial Appendage
System for Embolic Protection in Patients With Atrial Fibrillation) was conducted to determine …

[PDF][PDF] Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug

A Tzikas, S Shakir, S Gafoor, H Omran, S Berti… - …, 2016 - researchgate.net
Aims: To investigate the safety, feasibility, and efficacy of left atrial appendage occlusion
(LAAO) with the AMPLATZER Cardiac Plug (ACP) for stroke prevention in patients with atrial …